Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 15 studies | 46% ± 12% | |
| oligodendrocyte precursor cell | 13 studies | 43% ± 14% | |
| astrocyte | 12 studies | 37% ± 16% | |
| GABAergic neuron | 10 studies | 45% ± 21% | |
| glutamatergic neuron | 10 studies | 49% ± 23% | |
| endothelial cell | 9 studies | 27% ± 12% | |
| retinal ganglion cell | 5 studies | 48% ± 22% | |
| interneuron | 5 studies | 43% ± 21% | |
| amacrine cell | 4 studies | 25% ± 6% | |
| retinal rod cell | 4 studies | 58% ± 10% | |
| neuron | 3 studies | 30% ± 11% | |
| GABAergic interneuron | 3 studies | 50% ± 3% | |
| granule cell | 3 studies | 54% ± 22% | |
| mesothelial cell | 3 studies | 50% ± 23% | |
| glycinergic amacrine cell | 3 studies | 30% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 846.35 | 2631 / 2642 | 87% | 4.40 | 615 / 705 |
| thymus | 99% | 247.69 | 645 / 653 | 59% | 2.92 | 354 / 605 |
| stomach | 88% | 124.89 | 317 / 359 | 5% | 0.12 | 14 / 286 |
| ovary | 87% | 165.67 | 156 / 180 | 1% | 0.01 | 3 / 430 |
| uterus | 72% | 116.69 | 123 / 170 | 6% | 0.29 | 27 / 459 |
| muscle | 71% | 83.69 | 570 / 803 | 0% | 0 | 0 / 0 |
| prostate | 45% | 45.53 | 110 / 245 | 22% | 0.59 | 112 / 502 |
| esophagus | 55% | 80.19 | 801 / 1445 | 4% | 0.12 | 7 / 183 |
| intestine | 53% | 67.97 | 514 / 966 | 2% | 0.05 | 11 / 527 |
| kidney | 46% | 38.96 | 41 / 89 | 6% | 0.27 | 58 / 901 |
| adipose | 29% | 75.69 | 354 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 10% | 9.19 | 26 / 258 | 12% | 0.75 | 27 / 230 |
| blood vessel | 20% | 16.21 | 265 / 1335 | 0% | 0 | 0 / 0 |
| pancreas | 1% | 0.87 | 3 / 328 | 11% | 0.29 | 19 / 178 |
| lung | 1% | 1.33 | 7 / 578 | 6% | 0.27 | 70 / 1155 |
| bladder | 5% | 3.24 | 1 / 21 | 2% | 0.11 | 12 / 504 |
| skin | 2% | 1.46 | 33 / 1809 | 2% | 0.05 | 10 / 472 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.08 | 3 / 80 |
| breast | 2% | 1.66 | 10 / 459 | 1% | 0.03 | 10 / 1118 |
| liver | 0% | 0 | 0 / 226 | 3% | 0.06 | 11 / 406 |
| heart | 1% | 1.15 | 12 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0051260 | Biological process | protein homooligomerization |
| GO_0008277 | Biological process | regulation of G protein-coupled receptor signaling pathway |
| GO_0042995 | Cellular component | cell projection |
| GO_0043235 | Cellular component | receptor complex |
| GO_0042734 | Cellular component | presynaptic membrane |
| GO_0045211 | Cellular component | postsynaptic membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | KCTD8 |
| Protein name | Potassium channel tetramerization domain containing 8 BTB/POZ domain-containing protein KCTD8 |
| Synonyms | |
| Description | FUNCTION: Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity). . |
| Accessions | ENST00000360029.4 ENST00000515268.1 H0Y9S2 Q6ZWB6 |